The US Food and Drug Administration (FDA) Center for Tobacco Products (CTP) has published a number of milestones to expect in the near term as it continues to address issues brought up by the Reagan-Udall Foundation’s recent report.

As part of this – and potentially for the first time – the FDA CTP acknowledged the role alternatives to traditional cigarettes could play in smoking cessation and said it wanted science to inform future public awareness campaigns.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us